{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:39:41Z","timestamp":1760575181285,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2012ZX09301002-001-007","2012ZX09301002-006","2012ZX09103-101-001","81473096","81302847","81202545"],"award-info":[{"award-number":["2012ZX09301002-001-007","2012ZX09301002-006","2012ZX09103-101-001","81473096","81302847","81202545"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2012ZX09301002-001-007","2012ZX09301002-006","2012ZX09103-101-001","81473096","81302847","81202545"],"award-info":[{"award-number":["2012ZX09301002-001-007","2012ZX09301002-006","2012ZX09103-101-001","81473096","81302847","81202545"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2012ZX09301002-001-007","2012ZX09301002-006","2012ZX09103-101-001","81473096","81302847","81202545"],"award-info":[{"award-number":["2012ZX09301002-001-007","2012ZX09301002-006","2012ZX09103-101-001","81473096","81302847","81202545"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ejps.2020.105608","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T03:09:56Z","timestamp":1603681796000},"page":"105608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Insights into the metabolic characteristics of aminopropanediol analogues of SYLs as S1P1 modulators: from structure to metabolism"],"prefix":"10.1016","volume":"158","author":[{"given":"Manman","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baolian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2020.105608_bib0001","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1432-1033.1974.tb03890.x","article-title":"Structural studies of human liver alcohol dehydrogenase isoenzymes","volume":"50","author":"Berger","year":"1974","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejps.2020.105608_bib0002","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.C200176200","article-title":"The immune modulator FTY720 targets sphingosine 1-phosphate receptors","volume":"277","author":"Brinkmann","year":"2002","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.ejps.2020.105608_bib0003","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pharmthera.2005.05.002","article-title":"FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors","volume":"108","author":"Chiba","year":"2005","journal-title":"Pharmacology & therapeutics"},{"key":"10.1016\/j.ejps.2020.105608_bib0004","first-page":"11","article-title":"Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus","volume":"3","author":"Chiba","year":"2006","journal-title":"Cellular & Molecular Immunology"},{"key":"10.1016\/j.ejps.2020.105608_bib0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/sj.tpj.6500117","article-title":"Sulfation through the looking glass\u2013recent advances in sulfotransferase research for the curious","volume":"2","author":"Coughtrie","year":"2002","journal-title":"The pharmacogenomics journal"},{"key":"10.1016\/j.ejps.2020.105608_bib0006","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/tcm.1770140606","article-title":"Differences in teratogenic and toxic properties of alcohol dehydrogenase inhibitors pyrazole and 4-methylpyrazole in Drosophila melanogaster.\u2161","volume":"14","author":"Eisses","year":"1994","journal-title":"ADH allozymes in an isogenic background. Teratogenesis, Carcinogenesis, and Mutagenesis"},{"key":"10.1016\/j.ejps.2020.105608_bib0007","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0005-2736(78)90197-9","article-title":"Preparation of liver microsomes with high recovery of endoplasmic reticulum and a low grade of contamination","volume":"508","author":"Eriksson","year":"1978","journal-title":"Biochimica et biophysica acta"},{"key":"10.1016\/j.ejps.2020.105608_bib0008","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3109\/00498254.2010.506224","article-title":"Sources of variability in ketoconazole inhibition of human cytochrome P450 3A in vitro","volume":"40","author":"Greenblatt","year":"2010","journal-title":"Xenobiotica; the fate of foreign compounds in biological systems"},{"key":"10.1016\/j.ejps.2020.105608_bib0009","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jps.2600650806","article-title":"Oxidation of Selected Pteridine Derivatives by Mammalian Liver Xanthine Oxidase and Aldehyde Oxidase","volume":"65","author":"Hodnett","year":"1976","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ejps.2020.105608_bib0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bcp.2014.04.010","article-title":"Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis","volume":"90","author":"Jin","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ejps.2020.105608_bib0011","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1124\/dmd.110.035378","article-title":"CYP4F enzymes are responsible for the elimination of fingolimod (FTY720), a novel treatment of relapsing multiple sclerosis","volume":"39","author":"Jin","year":"2011","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"key":"10.1016\/j.ejps.2020.105608_bib0012","first-page":"362","article-title":"Identification of CYP2C19 inhibitors from phytochemicals using the recombinant human enzyme model","volume":"69","author":"Kong","year":"2013","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejps.2020.105608_bib0013","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1021\/tx00035a009","article-title":"Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline","volume":"6","author":"Kunze","year":"1993","journal-title":"Chemical Research in Toxicology"},{"key":"10.1016\/j.ejps.2020.105608_bib0014","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1124\/dmd.109.030270","article-title":"Identification of novel substrates for human cytochrome P450 2J2","volume":"38","author":"Lee","year":"2010","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"key":"10.1016\/j.ejps.2020.105608_bib0015","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bbalip.2008.06.006","article-title":"Sphingosine 1-phosphate chemical biology","volume":"1781","author":"Lynch","year":"2008","journal-title":"Biochimica et biophysica acta"},{"key":"10.1016\/j.ejps.2020.105608_bib0016","doi-asserted-by":"crossref","first-page":"38617","DOI":"10.1074\/jbc.M505974200","article-title":"Why is quinidine an inhibitor of cytochrome P450 2D6? The role of key active-site residues in quinidine binding","volume":"280","author":"McLaughlin","year":"2005","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.ejps.2020.105608_bib0017","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature02284","article-title":"Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1","volume":"427","author":"Mehrdad","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2020.105608_bib0018","article-title":"Identification of cytochrome P450 isoforms involved in the metabolism of Syl930, a selective S1PR1 agonist acting as a potential therapeutic agent for autoimmune encephalitis","author":"Mi","year":"2016","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.ejps.2020.105608_bib0019","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/FTD.0b013e3181b777f9","article-title":"Formulations of valproate alter valproate metabolism: a single oral dose kinetic study","volume":"31","author":"Nagai","year":"2009","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ejps.2020.105608_bib0020","series-title":"Potent inhibition of human liver aldehyde oxidase by raloxifene Drug metabolism and disposition: the biological fate of chemicals","first-page":"32","author":"Obach","year":"2004"},{"key":"10.1016\/j.ejps.2020.105608_bib0021","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00280-013-2296-5","article-title":"Effects of the aldehyde dehydrogenase inhibitor disulfiram on the plasma pharmacokinetics, metabolism, and toxicity of benzaldehyde dimethane sulfonate (NSC281612, DMS612","volume":"72","author":"Parise","year":"2013","journal-title":"BEN) in mice. Cancer Chemotherapy and Pharmacology"},{"key":"10.1016\/j.ejps.2020.105608_bib0022","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-2125.2002.01660.x","article-title":"Oxidation of celecoxib by polymorphic cytochrome P450 2C9 and alcohol dehydrogenase","volume":"54","author":"Sandberg","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejps.2020.105608_bib0023","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2125.1990.tb03686.x","article-title":"Furafylline is a potent and selective inhibitor of cytochrome P4501A2 in man","volume":"29","author":"Sesardic","year":"1990","journal-title":"Br. J. clin. Pharmac."},{"key":"10.1016\/j.ejps.2020.105608_bib0024","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.fitote.2016.12.002","article-title":"Stereoselective pharmacokinetics of 25-methoxyl-dammarane-3beta,12beta,20-triol and its active demethyl-metabolite epimers in rats after oral and intravenous administration","volume":"116","author":"Shao","year":"2017","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejps.2020.105608_bib0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpba.2015.03.025","article-title":"Development of a highly sensitive LC\u2013MS\/MS method for simultaneous determination of rupatadine and its two active metabolites in human plasma: Application to a clinical pharmacokinetic study","volume":"111","author":"Sun","year":"2015","journal-title":"Journal of pharmaceutical and biomedical analysis"},{"key":"10.1016\/j.ejps.2020.105608_bib0026","first-page":"369","article-title":"Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis","volume":"65","author":"Szeplaki","year":"2012","journal-title":"Ideggyogy Sz"},{"key":"10.1016\/j.ejps.2020.105608_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2014.07.081","article-title":"Discovery of oxazole and triazole derivatives as potent and selective S1P1 agonists through pharmacophore-guided design","volume":"85","author":"Tian","year":"2014","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejps.2020.105608_bib0028","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1016\/j.bmcl.2013.09.058","article-title":"Modulators of the Sphingosine 1-phosphate receptor 1","volume":"23","author":"Urbano","year":"2013","journal-title":"Bioorganic & medicinal chemistry letters"},{"key":"10.1016\/j.ejps.2020.105608_bib0029","first-page":"1","article-title":"The acetaminophen metabolite N-acetyl-p-benzoquinone imine (NAPQI) inhibits glutathione synthetase in vitro; a clue to the mechanism of 5-oxoprolinuric acidosis?","volume":"18","author":"Walker","year":"2016","journal-title":"Xenobiotica; the fate of foreign compounds in biological systems"},{"key":"10.1016\/j.ejps.2020.105608_bib0030","first-page":"9","article-title":"Stereoselective property of 20(S)-protopanaxadiol ocotillol type epimers affects its absorption and also the inhibition of P-glycoprotein","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2020.105608_bib0031","first-page":"989","article-title":"Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis","volume":"13","author":"Ward","year":"2014","journal-title":"Drug Safety Evaluation"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720303961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720303961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:54:14Z","timestamp":1760529254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098720303961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":31,"alternative-id":["S0928098720303961"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105608","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into the metabolic characteristics of aminopropanediol analogues of SYLs as S1P1 modulators: from structure to metabolism","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105608"}}